From December, 1985 to June, 1991, 181 cases of palliative urinary diversions were performed at Mackay Memorial Hospital. Among these cases, there were 104 (57.5%) percutaneous nephrostomies, 68 (37.6%) double-J ureteral steents, and only 9 cutaneous ureterostomies (4.9%). Cutaneous ureterostomy was performed to correct fistula formation in four cases (three cervical and one rectal cancers), persistent hematuria from lower urinary tract in four cases, and initial treatment for late stage bladder cancer in one. There were no operative mortalities in these nine cases. The two complications – one ureteral necrosis and one obstruction from kinking – were resolved easily. The patients lived for 8 to 910 days, with an average of 311 days. Five of the patients lived for more than six months. With the advent of simpler and safer techniques of percutaneous nephrostomy and double-J ureteral stents, cutaneous ureterostomy is no longer a primary palliative procedure for treatment of pelvic malignancy. However, this procedure is recommended only selectively in high-risk patients with advanced pelvic cancer with life expectancy of more than three months, persistent hematuria or urinary fistula formation, and when double-J insertion or percutaneous nephropstomy fails.